These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transfer factor (TFd). Part I. Some physicochemical data. Komorowska-Rycerz A; Szczypiorska D; Izdebska-Szymona K; Kociński W; Zarzycka A; Rzucidło L Mater Med Pol; 1979; 11(4):317-9. PubMed ID: 553982 [No Abstract] [Full Text] [Related]
3. Studies on the chemical composition and biological properties of transfer factor. Krohn K; Uotila A; Väisänen J; Gröhn P Z Immunitatsforsch Immunobiol; 1977 Dec; 153(5):395-411. PubMed ID: 602344 [TBL] [Abstract][Full Text] [Related]
4. Characterization of Tx, an active subfraction of human dialyzable transfer factor. I. Identification of the major component in TFg, a precursor of Tx, as hypoxanthine. Wilson GB; Welch TM; Knapp DR; Horsmanheimo A; Fudenberg HH Clin Immunol Immunopathol; 1977 Nov; 8(3):551-68. PubMed ID: 912950 [No Abstract] [Full Text] [Related]
5. Human transfer factor: fractionation by electrofocusing and high pressure, reverse phase chromatography. Vandenbark AA; Burger DR; Dreyer DL; Daves GD; Vetto RM J Immunol; 1977 Feb; 118(2):636-41. PubMed ID: 839073 [TBL] [Abstract][Full Text] [Related]
6. The effect of transfer factor on cystic acne. Gröhn P; Kuokkanen K; Krohn K Acta Derm Venereol; 1978; 58(2):153-5. PubMed ID: 76396 [TBL] [Abstract][Full Text] [Related]
7. Fractionation studies on human leucocyte dialyzates. Demonstration of three components with transfer factor activity. Krohn K; Gröhn P; Horsmanheimo M; Virolainen M Med Biol; 1976 Dec; 54(5):334-40. PubMed ID: 994567 [TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of immunopeptide from dialyzable leukocyte extract. Khan A; Garrison O; Hill JM; Antonetti A; Hill NO; Gracy RW Cell Immunol; 1980 Oct; 55(2):420-7. PubMed ID: 7428052 [No Abstract] [Full Text] [Related]
9. Identification of hypoxanthine as the major compoenet of a chromatographic fraction of transfer factor. O'Dorisio MS; Neidhart JA; Daniel FB; Balcerzak SP; LoBuglio AF Cell Immunol; 1976 May; 23(2):191-202. PubMed ID: 1277303 [No Abstract] [Full Text] [Related]
10. The identification and significance of hypoxanthine in dialyzable transfer factor. Kirkpatrick CH; Robinson LB; Smith TK Cell Immunol; 1976 Jun; 24(2):230-40. PubMed ID: 181148 [No Abstract] [Full Text] [Related]
12. Determination and separation of some uracil herbicides by thin-layer chromatography. von Stryk FG; Zajacz GF J Chromatogr; 1969 Apr; 41(1):125-6. PubMed ID: 5780857 [No Abstract] [Full Text] [Related]
13. Human transfer factor in vitro: identification of L-serine and glycine as components with augmenting effect in lymphocyte transformation assay. Uotila A; Marnela KM; Hamblin A; Krohn K Scand J Immunol; 1978; 7(6):495-502. PubMed ID: 684376 [No Abstract] [Full Text] [Related]
14. Transfer factor. Baram P IMJ Ill Med J; 1976 May; 149(5):448-52, 484. PubMed ID: 6377 [No Abstract] [Full Text] [Related]
17. Transfer factor: hypoxanthine is a major component of a fraction with in vivo activity. Tomar RH; Knight R; Stern M J Allergy Clin Immunol; 1976 Jul; 58(1 PT. 2):190-7. PubMed ID: 956555 [TBL] [Abstract][Full Text] [Related]
18. A method for the determination of Venzar (3-cyclohexyl-5,6-trimethyluracil) on silica gel layers. Kosinkiewicz B; Lubczynska J J Chromatogr; 1972 Dec; 74(2):366-8. PubMed ID: 4345689 [No Abstract] [Full Text] [Related]
19. Thymine: a possible prebiotic synthesis. Stephen-Sherwood E; Oro J; Kimball AP Science; 1971 Jul; 173(3995):446-7. PubMed ID: 5557323 [TBL] [Abstract][Full Text] [Related]
20. Characterization of human dialyzable transfer factor from normal and chronic lymphoid leukemia sources. Goust JM; Marescot MR; Lesourd B; Doumercq S; Moulias R Biomedicine; 1976 Jan; 24(1):39-44. PubMed ID: 817750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]